©The Author(s) 2025.
World J Clin Pediatr. Dec 9, 2025; 14(4): 109476
Published online Dec 9, 2025. doi: 10.5409/wjcp.v14.i4.109476
Published online Dec 9, 2025. doi: 10.5409/wjcp.v14.i4.109476
Table 9 Summarized details of emerging metabolic biomarkers for diagnosis and early prediction of gestational diabetes mellitus and associated outcomes
| Biomarker | Amino acid/metabolic pathway | Potential role | Ref. |
| Metabolic biomarkers | |||
| Amino acid metabolites | |||
| Branched-chain amino acids | Leucine, isoleucine, valine | Associated with insulin resistance and GDM | Li et al[134], Ademolu[135] |
| Tryptophan | Tryptophan | Involved in various metabolic processes and altered tryptophan metabolism have been linked to insulin resistance and GDM | Zhou et al[136], Özdemir et al[137] |
| Phenylalanine | Phenylalanine | Elevated phenylalanine levels have been linked to insulin resistance and GDM | Yang et al[138] |
| Histidine | Histidine | Modified histidine concentrations have been associated with insulin resistance and GDM | Zhou et al[136], Yang et al[138] |
| Glutamic acid | Glutamic acid | Potential biomarker for GDM diagnosis | Yang et al[138], Kong et al[139] |
| N-Acetylproline | Proline | Altered N-Acetylproline levels have been linked to insulin resistance and GDM | Aleidi et al[140] |
| Alanine | Alanine | Potential biomarker for GDM diagnosis | Zhou et al[141], Spanou et al[142] |
| Tyrosine | Tyrosine | Potential biomarker for GDM prediction | Yang et al[138], Spanou et al[142] |
| Arginine | Arginine | Employed in glucose metabolism and GDM | Spanou et al[142], Zhan et al[143] |
| Glycine | Glycine | Associated with insulin sensitivity and GDM | Yang et al[138], Zhou et al[141], Spanou et al[142] |
| Lipid metabolites | |||
| Triacylglycerols | Insulin resistance-related lipid metabolites | Potential biomarkers for GDM prediction | Zhang et al[144], Balachandiran et al[145] |
| Inositol phosphate | Insulin resistance and glucose metabolism | Insulin resistance and glucose intolerance in GDM may be exacerbated by altered IP3 signaling | Pillai et al[146], Mazzera et al[147] |
| Glycerolipid | GDM and insulin resistance may exacerbate by elevated triacylglycerols | Predictive biomarker for GDM risk | Zhan et al[143], Zhang et al[144] |
| Omega-6-fatty acid | Changes in amino acid levels might be a factor in GDM and insulin resistance | Predictive biomarker for GDM risk | Egalini et al[132], Hosseinkhani et al[148] |
| Phosphatidylcholines | Phospholipids involved in glucose metabolism | Potential biomarkers for GDM diagnosis | Zhou et al[141], Wang et al[149] |
| Sphingomyelins | Sphingolipids associated with insulin resistance | Potential biomarkers for GDM prediction | Fakhr et al[150], Pinto et al[151] |
| Lysophosphatidylcholines | Phospholipid metabolites associated with GDM | Potential biomarkers for GDM diagnosis | Zhou et al[141], Zhan et al[143], Hung et al[152] |
| Ceramides | Sphingolipids associated with insulin resistance | Potential biomarkers for GDM prediction | Mustaniemi et al[153], Lantzanaki et al[154] |
| Free fatty acids | Lipid metabolites associated with insulin resistance | Potential biomarkers for GDM prediction | Kong et al[139], Hosseinkhani et al[148] |
| Acylcarnitines | Fatty acid metabolites associated with insulin resistance | Potential biomarkers for GDM prediction | Zhan et al[143], Pinto et al[151] |
| Glycolytic intermediates | |||
| 1,5-Anhydroglucitol | Glycolysis | Marker of glycemic control and GDM diagnosis | Xu et al[155], Lin et al[156] |
| Pyruvate | Glycolysis | Potential biomarker for GDM diagnosis | Zhou et al[141], Bhushan et al[157] |
| Glyceraldehyde-3-phosphate | Glycolysis | Potential biomarker for GDM prediction | Saucedo et al[61] |
| Lactate | Glycolysis | Associated with insulin resistance and GDM | Zhou et al[141] |
| Fructose-1,6-bisphosphate | Glycolysis | Potential biomarker for GDM prediction | Wei et al[158], Wang et al[159] |
| Glucose-6-phosphate | Glycolysis | Potential biomarker for GDM diagnosis | Wei et al[158] |
| Phosphoenolpyruvate | Glycolysis | Potential biomarker for GDM prediction | Lai et al[160], Xu et al[161] |
- Citation: Gautam T, Shamsad A, Singh R, Banerjee M. Emerging biomarkers for gestational diabetes mellitus and related pediatric outcomes. World J Clin Pediatr 2025; 14(4): 109476
- URL: https://www.wjgnet.com/2219-2808/full/v14/i4/109476.htm
- DOI: https://dx.doi.org/10.5409/wjcp.v14.i4.109476